8-142700588-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017527.4(LY6K):āc.61C>Gā(p.Leu21Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000028 in 1,426,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_017527.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LY6K | NM_017527.4 | c.61C>G | p.Leu21Val | missense_variant | 1/3 | ENST00000292430.10 | NP_059997.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LY6K | ENST00000292430.10 | c.61C>G | p.Leu21Val | missense_variant | 1/3 | 1 | NM_017527.4 | ENSP00000292430.6 | ||
LY6K | ENST00000519387.1 | c.61C>G | p.Leu21Val | missense_variant | 1/3 | 2 | ENSP00000429695.1 | |||
LY6K | ENST00000518841.5 | c.61C>G | p.Leu21Val | missense_variant | 1/3 | 2 | ENSP00000427749.1 | |||
LY6K | ENST00000522591.1 | c.61C>G | p.Leu21Val | missense_variant | 1/2 | 2 | ENSP00000428432.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000280 AC: 4AN: 1426930Hom.: 0 Cov.: 35 AF XY: 0.00000282 AC XY: 2AN XY: 709022
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2022 | The c.61C>G (p.L21V) alteration is located in exon 1 (coding exon 1) of the LY6K gene. This alteration results from a C to G substitution at nucleotide position 61, causing the leucine (L) at amino acid position 21 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.